The U.S. Food and Drug Administration is planning to authorize a third dose of the COVID-19 vaccine for people with weakened immune systems in a decision that could come as soon as Thursday, according to the New York Times, as the delta variant continues to spread fast across the U.S.
The U.S. Food and Drug Administration is planning to authorize a third dose of the COVID-19 vaccine for people with weakened immune systems in a decision that could come as soon as Thursday, according to the New York Times, as the delta variant continues to spread fast across the U.S.